Life-Science Instruments & Consumables
Lab instruments; analytical tools; reagents; genomics tools; bioprocess equipment.
NTM Growth %
to
EV / NTM Rev (x)
to
Mkt Cap ($B)
to
Showing 7 of 7 companies
| Company | Mkt Cap ↓ | EV | EV / LTM Rev | EV / NTM Rev | EV / LTM EBITDA | EV / NTM EBITDA | NTM Growth | Gross Margin | EBITDA Margin | FCF Margin | Rule of 40 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | 5.9x | 5.2x | 22.2x | 18.5x | 10.0% | 53.0% | 23.6% | 18.1% | 27.1% | |||
| Mean | 5.8x | 5.4x | 25.7x | 20.2x | 8.3% | 54.6% | 21.4% | 16.7% | 25.0% | |||
| TMOThermo Fisher Scientific Inc. | $211.06B | $249.55B | 5.6x | 5.1x | 21.8x | 18.5x | 10.7% | 40.4% | 23.6% | 16.4% | 27.1% | |
| DHRDanaher Corporation | $138.50B | $160.71B | 6.5x | 5.8x | 23.1x | 18.3x | 12.0% | 58.5% | 25.6% | 22.2% | 34.3% | |
| AAgilent Technologies, Inc. | $39.28B | $40.83B | 5.9x | 5.2x | 22.2x | 19.3x | 12.1% | 53.0% | 27.1% | 18.1% | 30.2% | |
| ILMNIllumina, Inc. | $30.17B | $31.53B | 7.3x | 6.6x | 21.6x | — | 10.0% | 66.8% | 30.3% | 21.6% | 31.6% | |
| TECHBio-Techne Corporation | $11.29B | $11.37B | 9.3x | 8.9x | 52.4x | 29.9x | 4.4% | 65.0% | 21.3% | 22.1% | 26.5% | |
| BIOBio-Rad Laboratories, Inc. | $9.03B | $8.84B | 3.4x | 3.4x | 7.1x | — | 1.7% | 51.9% | 18.1% | 13.8% | 15.5% | |
| BRKRBruker Corporation | $7.83B | $9.47B | 2.8x | 2.6x | 31.3x | 15.0x | 7.1% | 46.4% | 3.9% | 2.7% | 9.8% |